Review article · 2026 · Open access

Mapping the prevalence of molecular markers of Plasmodium falciparum artemisinin partial resistance in Africa: a systematic review and spatiotemporal modelling study

Neeva Wernsman Young, Cecile P. G. Meier-Scherling, Gina Cuomo-Dannenburg, George A. Tollefson, Sean V. Connelly, Jacob Marglous, Isabela Gerdes Gyuricza, Kelly Carey-Ewend, Ronald Futila Kyong-Shin, Zachary R. Popkin-Hall, Ayalew Jejaw Zeleke, Deus S. Ishengoma and 11 more

The Lancet Infectious Diseases, 26(11), 1154–1165 · Published 7 July 2026 · DOI 10.1016/s1473-3099(26)00237-9

Open full textCite this paper

In brief

“Mapping the prevalence of molecular markers of Plasmodium falciparum artemisinin partial resistance in Africa: a systematic review and spatiotemporal modelling study” is a 2026 review article by Neeva Wernsman Young and 22 co-authors, published in The Lancet Infectious Diseases. OpenAlex counts 5 citations as of 19 November 2026, which puts it in the top 3% of works published in 2026 by citations. It is open access under a CC BY licence: the full text is free to read at The Lancet Infectious Diseases.

Citations
5
Most cited in
2026 (5)
Field-weighted impact
4.36
References
53
Authors
23

Abstract

Background Plasmodium falciparum kelch13(k13) mutations in Africa signal emerging artemisinin partial resistance (ART-R), endangering malaria control by undermining artemisinin-based combination therapies (ACTs). Sparse surveillance obscures whether rising k13 ART-R prevalence reflects local emergence or geographical expansion. We aimed to model and infer high-resolution spatiotemporal prevalence of k13 ART-R mutations, as well as mdr1 and crt mutations (markers of reduced susceptibility to ACT partner drugs), to inform public health policy. Methods For this systematic review and modelling analysis, we searched PubMed, Ovid MEDLINE, and Web of Science databases for English-language primary studies reporting malaria resistance, conducted in Africa, reporting pretreatment P falciparum samples with genotyping of k13 (all codons), mdr1 N86Y, or crt K76T, and that provided sufficient survey time and location metadata and complete, primary data, published between Sept 25, 2014, and July 9, 2025, with data extracted from full-text reports. Studies identified during the systematic review were added to 11 privately held datasets that met the same eligibility criteria but were unpublished at the time of review to give the augmented systematic review. Studies from the augmented systematic review were added to existing data from the Worldwide Antimalarial Resistance Network molecular surveyor (WWARN), MalariaGEN Pf8, and the WHO malaria threats map (WHO MTM), with any duplicates removed. The integrated dataset was harmonised by use of a standardised data schema. We estimated the continuous prevalence of each mutation using a spatiotemporal Gaussian process model and summarised with median and 95% credible intervals over posterior draws. The study was registered with PROSPERO (CRD42024593923). Findings We identified 1119 articles during the database search, with 120 studies included in the final analysis. These were augmented with 11 privately held datasets. In total, the augmented systematic review identified 131 unique studies. Data from public repositories (WWARN, Pf8, and WHO MTM) provided an additional 447 studies after removal of duplicates. The final dataset included 93 887 samples sequenced at target k13 positions and 185 099 samples sequenced for either k13 , crt K76T, or mdr1 N86Y, drawn from 578 studies encompassing 3848 distinct surveys across 47 African countries. Modelling showed distinct emergences of k13 R561H in Rwanda, k13 A675V and C469Y in Uganda, and k13 R622I in Ethiopia and Eritrea. The highest predicted prevalence of k13 mutations in 2024 was observed in Northern Province, Rwanda, at 62·2% (95% credible interval 3·9–98·6), increasing from 0·2% (0·0–0·7) in 2012 at an average annual increase of 5·2 percentage points. Modelling indicated a rapid transition from localised k13 ART-R mutation emergence to entrenched regional hot spots covering most of…

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Young, N. W., Meier-Scherling, C. P. G., Cuomo-Dannenburg, G., Tollefson, G. A., Connelly, S. V., Marglous, J., Gyuricza, I. G., Carey-Ewend, K., Kyong-Shin, R. F., Popkin-Hall, Z. R., Zeleke, A. J., Ishengoma, D. S., Fola, A. A., Simkin, A., Niaré, K., Parr, J. B., Conrad, M. D., Okell, L., Ruybal‐Pesántez, S., . . . Verity, R. (2026). Mapping the prevalence of molecular markers of Plasmodium falciparum artemisinin partial resistance in Africa: a systematic review and spatiotemporal modelling study. The Lancet Infectious Diseases, 26(11), 1154–1165. https://doi.org/10.1016/s1473-3099(26)00237-9

MLA 9

Young, Neeva Wernsman, et al. “Mapping the prevalence of molecular markers of Plasmodium falciparum artemisinin partial resistance in Africa: a systematic review and spatiotemporal modelling study.” The Lancet Infectious Diseases, vol. 26, no. 11, 2026, pp. 1154–1165. https://doi.org/10.1016/s1473-3099(26)00237-9.

Chicago

Young, Neeva Wernsman, Cecile P. G. Meier-Scherling, Gina Cuomo-Dannenburg, George A. Tollefson, Sean V. Connelly, Jacob Marglous, Isabela Gerdes Gyuricza, et al. 2026. “Mapping the prevalence of molecular markers of Plasmodium falciparum artemisinin partial resistance in Africa: a systematic review and spatiotemporal modelling study.” The Lancet Infectious Diseases 26 (11): 1154–1165. https://doi.org/10.1016/s1473-3099(26)00237-9.

Harvard

Young, N. W. et al. (2026) ‘Mapping the prevalence of molecular markers of Plasmodium falciparum artemisinin partial resistance in Africa: a systematic review and spatiotemporal modelling study’, The Lancet Infectious Diseases, 26(11), pp. 1154–1165. doi:10.1016/s1473-3099(26)00237-9.

IEEE

N. W. Young et al., “Mapping the prevalence of molecular markers of Plasmodium falciparum artemisinin partial resistance in Africa: a systematic review and spatiotemporal modelling study,” The Lancet Infectious Diseases, vol. 26, no. 11, pp. 1154–1165, 2026, doi: 10.1016/s1473-3099(26)00237-9.

BibTeX

@article{young2026mapping,
  title     = {{Mapping the prevalence of molecular markers of Plasmodium falciparum artemisinin partial resistance in Africa: a systematic review and spatiotemporal modelling study}},
  author    = {Young, Neeva Wernsman and Meier-Scherling, Cecile P. G. and Cuomo-Dannenburg, Gina and Tollefson, George A. and Connelly, Sean V. and Marglous, Jacob and Gyuricza, Isabela Gerdes and Carey-Ewend, Kelly and Kyong-Shin, Ronald Futila and Popkin-Hall, Zachary R. and Zeleke, Ayalew Jejaw and Ishengoma, Deus S. and Fola, Abebe Alemu and Simkin, Alfred and Niaré, Karamoko and Parr, Jonathan B. and Conrad, Melissa D. and Okell, Lucy and Ruybal‐Pesántez, Shazia and Watson, Oliver John and Juliano, Jonathan J. and Bailey, Jeffrey A. and Verity, Robert},
  journal   = {The Lancet Infectious Diseases},
  year      = {2026},
  volume    = {26},
  number    = {11},
  pages     = {1154--1165},
  doi       = {10.1016/s1473-3099(26)00237-9},
  url       = {https://doi.org/10.1016/s1473-3099(26)00237-9}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control

  • Plasmodium falciparum
  • kelch13 mutations
  • antimalarial drug resistance
  • artemisinin-based combination therapy
  • chloroquine resistance

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Young, N. W., Meier-Scherling, C. P. G., Cuomo-Dannenburg, G., Tollefson, G. A., Connelly, S. V., Marglous, J., Gyuricza, I. G., Carey-Ewend, K., Kyong-Shin, R. F., Popkin-Hall, Z. R., Zeleke, A. J., Ishengoma, D. S., Fola, A. A., Simkin, A., Niaré, K., Parr, J. B., Conrad, M. D., Okell, L., Ruybal‐Pesántez, S., . . . Verity, R. (2026). Mapping the prevalence of molecular markers of Plasmodium falciparum artemisinin partial resistance in Africa: a systematic review and spatiotemporal modelling study. The Lancet Infectious Diseases, 26(11), 1154–1165. https://doi.org/10.1016/s1473-3099(26)00237-9

How many times has this paper been cited?

5 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at The Lancet Infectious Diseases: sign in and open the full text from this page.

Who wrote this paper?

Neeva Wernsman Young, Cecile P. G. Meier-Scherling, Gina Cuomo-Dannenburg, George A. Tollefson, Sean V. Connelly, Jacob Marglous, Isabela Gerdes Gyuricza, Kelly Carey-Ewend, Ronald Futila Kyong-Shin, Zachary R. Popkin-Hall, Ayalew Jejaw Zeleke, Deus S. Ishengoma and 11 more.

What is the DOI of this paper?

10.1016/s1473-3099(26)00237-9, permanently at https://doi.org/10.1016/s1473-3099(26)00237-9. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.